Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A new study lacked significant results, but when combined with additional studies, the prevention of cardiovascular events ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

The therapeutic approach was safe, but the study did not meet its primary efficacy outcome using the six-minute walking test.

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

Researchers report a discovery in cardiac regeneration that offers new hope for the treatment of ischemic heart failure. Published in npj Regenerative Medicine, the study reveals a novel approach ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart ...

CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, ...